A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 1. Construction of the basic framework.
暂无分享,去创建一个
T. Inoue | H. Kayakiri | N. Inamura | K. Imai | C. Hatori | M. Asano | S. Satoh | Y. Abe | Y. Sawada | T. Oku | H. Tanaka | A. Katayama | H. Tanaka